Supraventricular Tachyarrhythmias

• FDA approval · 2019-10-01
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)

  The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…

• CLINICAL_TRIALS trial_result · 2015-09-23
  Clinical Trial Update: Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias [Phase 2]

  An update on a Phase 2 clinical trial evaluating botulinum toxin injections to prevent secondary atrial fibrillation in patients with suprav…